These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 35237783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine-addicted OSCC cells.
    Luo Y, Li W, Ling Z, Hu Q, Fan Z, Cheng B, Tao X.
    Cancer Med; 2020 May; 9(10):3489-3499. PubMed ID: 32162845
    [Abstract] [Full Text] [Related]

  • 3. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L, Liu Y, Zhao TL, Li ZZ, He JY, Zhang BJ, Du HZ, Jiang JW, Yuan ST, Sun L.
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [Abstract] [Full Text] [Related]

  • 4. Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development.
    Wang Q, Hardie RA, Hoy AJ, van Geldermalsen M, Gao D, Fazli L, Sadowski MC, Balaban S, Schreuder M, Nagarajah R, Wong JJ, Metierre C, Pinello N, Otte NJ, Lehman ML, Gleave M, Nelson CC, Bailey CG, Ritchie W, Rasko JE, Holst J.
    J Pathol; 2015 Jul; 236(3):278-89. PubMed ID: 25693838
    [Abstract] [Full Text] [Related]

  • 5. Lobetyolin inhibits the proliferation of breast cancer cells via ASCT2 down-regulation-induced apoptosis.
    Chen Y, Tian Y, Jin G, Cui Z, Guo W, Zhang X, Liu X.
    Hum Exp Toxicol; 2021 Dec; 40(12):2074-2086. PubMed ID: 34075790
    [Abstract] [Full Text] [Related]

  • 6. LncRNA SLC1A5-AS/MZF1/ASCT2 Axis Contributes to Malignant Progression of Hepatocellular Carcinoma.
    Jiang J, Dong W, Zhang W, Wang Q, Wang R, Wang J, Wu H, Dong H, Zhao RC, Wang J, Li Z.
    Discov Med; 2023 Dec; 35(179):995-1014. PubMed ID: 38058065
    [Abstract] [Full Text] [Related]

  • 7. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
    Zhang Z, Liu R, Shuai Y, Huang Y, Jin R, Wang X, Luo J.
    Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. ASCT2 is a major contributor to serine uptake in cancer cells.
    Conger KO, Chidley C, Ozgurses ME, Zhao H, Kim Y, Semina SE, Burns P, Rawat V, Lietuvninkas L, Sheldon R, Ben-Sahra I, Frasor J, Sorger PK, DeNicola GM, Coloff JL.
    Cell Rep; 2024 Aug 27; 43(8):114552. PubMed ID: 39068660
    [Abstract] [Full Text] [Related]

  • 17. Sorting nexin 27 (SNX27) regulates the trafficking and activity of the glutamine transporter ASCT2.
    Yang Z, Follett J, Kerr MC, Clairfeuille T, Chandra M, Collins BM, Teasdale RD.
    J Biol Chem; 2018 May 04; 293(18):6802-6811. PubMed ID: 29563155
    [Abstract] [Full Text] [Related]

  • 18. Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy.
    Jiang H, Zhang N, Tang T, Feng F, Sun H, Qu W.
    Pharmacol Res; 2020 Aug 04; 158():104844. PubMed ID: 32438035
    [Abstract] [Full Text] [Related]

  • 19. Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors via the transporter ASCT2.
    Zhou P, Liang X, Zhou C, Qin J, Hou C, Zhu Z, Zhang W, Wang S, Zhong D.
    J Mater Chem B; 2019 Sep 11; 7(35):5363-5375. PubMed ID: 31403158
    [Abstract] [Full Text] [Related]

  • 20. Characterizing unexpected interactions of a glutamine transporter inhibitor with members of the SLC1A transporter family.
    Freidman NJ, Briot C, Ryan RM.
    J Biol Chem; 2022 Aug 11; 298(8):102178. PubMed ID: 35752361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.